top of page

The RetiSpec Mission

RetiSpec believes a better future for Alzheimer’s starts with the ability to diagnose it. Our mission is to enable widespread early and accurate detection of neurodegenerative disease markers, with accessible, affordable, and scalable retinal screening. To achieve this vision, RetiSpec is developing explainable AI (XAI) for the early detection of Alzheimer’s  disease through a simple eye test.

Board of Directors

Eliav Shaked, MSc

CEO & Co-founder, RetiSpec


Founder and Managing Partner, iGan Partners 

Roy Kirshon, MBA

COO & Co-founder, RetiSpec

Robert Vance, BA (Observer)

Vice President of New Markets, Gentex Corporation

bottom of page